The Chinese Solar Machine Layer by Layer Fire in the Library The Mystery Behind Anesthesia
Finger prick to protein: A microfluidic chip identifies 35 proteins in a drop of blood within 10 minutes. The entire analysis process is performed on the chip. First, blood cells are separated from protein-rich serum, which travels down the narrow channels. These channels are coated with protein-capturing bar codes that light up under a fluorescent microscope if the blood drop contained the protein of interest.
James Heath
A cheap chip rapidly identifies cancer proteins in a drop of blood.
Measuring proteins in the blood can help doctors determine patients' cancer risk and monitor the health of the elderly and people with chronic diseases. But current methods for testing these proteins are too expensive and require too much blood to be performed regularly. A microfluidic chip in clinical trials does on a single chip in 10 minutes what normally takes multiple technicians hours to do--and with just a single drop of blood. Researchers hope to make bedside diagnostics based on blood proteins a reality by bringing down the cost of such tests by at least an order of magnitude.
The diagnostic chip is being developed by Caltech chemistry professor James Heath and by Leroy Hood, the president and founder of the Institute for Systems Biology, in Seattle. Heath and Hood have founded a company called Integrated Diagnostics to commercialize the blood chip.
"Serum proteins provide an incredible window into the biology of disease," says Paul Mischel, a professor of pathology at the University of California, Los Angeles. But today, it costs about $500 to test for one blood protein, and these tests require 10 to 15 milliliters of blood and multiple visits to the doctor.
"We decided to make things dirt cheap: it costs a nickel a protein," Heath says of the current device. Such rapid and cheap tests requiring only a drop of blood should allow doctors to monitor more proteins more frequently, enabling earlier detection of diseases like cancer and better preventive care for the elderly. The new diagnostics should also be more accurate, says Heath. Traditional blood samples sit for hours or even days before the measurement process is completed, allowing plenty of time for them to degrade.
Heath and Hood's device, described in this week's issue of Nature Biotechnology, starts the analysis process with some simple microfluidics. A drop of blood is pulled down a microscale channel by the application of a small external pressure. This first channel branches off into narrower ones, which exclude blood cells and admit the protein-rich blood serum. In typical blood tests, this separation step requires a centrifuge.
The narrower channels are patterned with what Heath calls a protein bar code--lines of DNA bound to antibodies that capture proteins of interest from the serum. After the serum and cells are flushed out, antibodies bound to red fluorescent proteins are flushed in, lighting up captured blood proteins. The protein bar codes can be read under a fluorescent microscope or a gene-chip scanner. The identity of the captured blood proteins can be determined by the location of red lines in the bar code relative to a green fluorescent reference line.
Manufacturing in the United States is in trouble. That's bad news not just for the country's economy but for the future of innovation.
trebaryar
4 Comments
Ten-Minute Blood Test
Sure wish the authors of these "Gee Whiz" breakthroughs would include a best guess estimate from the developers of when we could expect their product to be commercially available. "In the Future" for someone desperately waiting is annoying for someone 68yrs old.
Reply